GW&K Investment Management’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
VCM
VPM
GW&K Investment Management's HALO Position: Q1 2026 in Review
GW&K Investment Management increased its Halozyme (HALO) stake by 11% in Q1 2026, buying an estimated $9.81M and bringing the position to 1,393,875 shares worth $90.1M. The position accounts for 0.79% of the portfolio, ranked #26.
GW&K Investment Management first reported a position in HALO in Q4 2020 and has held it in 22 quarters since. The position peaked at $119M in Q4 2022. 635 funds tracked by Wall St. Rank hold HALO as of Q1 2026.
- GW&K Investment Management held 1,393,875 shares of Halozyme worth $90.1M as of Q1 2026.
- GW&K Investment Management bought 139,227 Halozyme shares in Q1 2026, an estimated $9.81M.
- Halozyme made up 0.79% of GW&K Investment Management's portfolio in Q1 2026, its #26 holding.
- GW&K Investment Management first reported a position in Halozyme in Q4 2020 and has held it in 22 quarters since.
- GW&K Investment Management's Halozyme position peaked at $119M in Q4 2022.
- 635 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.
Based on GW&K Investment Management's 13F filing for Q1 2026, filed 13 May 2026.